Follow Us:

Tag: Vaccine

16 Results

  • Misinformation about COVID-19 pandemic more dangerous says UN Chief

    Misinformation about COVID-19 pandemic more dangerous says UN Chief

    'This is a time for science and solidarity', said the UN General Secretary Antonio Guterres.

    April 15, 2020
  • ‘Germany not for sale’, country’s minister says after Trump offers to buy exclusive access to Covid-19 vaccine

    ‘Germany not for sale’, country’s minister says after Trump offers to buy exclusive access to Covid-19 vaccine

    CureVac said in a statement Sunday that it 'abstains from commenting on speculations and rejects allegations about offers for the acquisition of the company or its technology'.

    March 16, 2020
  • Coronavirus: World Health Organisation issues appeal for $675 million to fight novel disease

    Coronavirus: World Health Organisation issues appeal for $675 million to fight novel disease

    WHO Chief hailed a $100 million donation from the Bill and Melinda Gates Foundation announced earlier on Wednesday for virus testing, treatment and vaccine research.

    February 6, 2020
  • Refusal to vaccine: refusal to a healthy life

    Refusal to vaccine: refusal to a healthy life

    The truth that most people do not realise about vaccines is that failing to get immunized on time can make you more susceptible to any illness.

    April 30, 2019
  • World’s first and only malaria vaccine launched in Africa: WHO

    World’s first and only malaria vaccine launched in Africa: WHO

    Malawi is the first of three in Africa where RTS,S is to be made available to children up to two years of age.

    April 24, 2019
  • PaxVax’s cholera vaccine can control outbreaks quickly

    PaxVax’s cholera vaccine can control outbreaks quickly

    A single-dose cholera vaccine marketed by PaxVax, a global biotechnology company based in California, can provide faster protection in epidemics, thereby helping control big outbreaks more quickly, suggest results of a trial. While the standard regimen for protecting against cholera with existing non-living oral cholera vaccines includes administering two doses over a two-week period, the...

    December 12, 2017
  • Can HPV vaccine reduce Pap tests?

    Can HPV vaccine reduce Pap tests?

    'This is great news for women. The cervical screening programme is already very successful'

    November 13, 2017
  • HPV vaccine may prevent childhood respiratory disease

    HPV vaccine may prevent childhood respiratory disease

    'This is a world-first finding of evidence that the HPV vaccine has actually prevented recurrent respiratory papillomatosis cases'.

    November 10, 2017
  • Five new malaria vaccine targets identified

    Five new malaria vaccine targets identified

    Scientists discovered that different antibodies were attacking the parasite at different steps as it invaded the red blood cell. 

    October 25, 2017
  • Experimental HIV vaccine is well-tolerated in adults

    Experimental HIV vaccine is well-tolerated in adults

    Researchers have found that an investigational HIV vaccine regimen was well-tolerated and generated immune responses against the deadly virus in healthy adults. The findings by APPROACH — an early-stage clinical trial — are based on "mosaic" technology that combines immune-stimulating proteins from four different HIV strains, representing different types of virus from around the globe....

    July 25, 2017
  • Indian ‘vaccine billionaire’ buys Gandhi’s rare portrait and letters

    Indian ‘vaccine billionaire’ buys Gandhi’s rare portrait and letters

    A rare 1931 pencil portrait of Mahatma Gandhi and a collection of his handwritten letters that went under the hammer at the Sothebys auction here have been bought by noted Indian businessman Cyrus Poonawalla, popularly known as the 'vaccine billionaire'. Poonawalla founded the Serum Institute of India in 1966, today one of the world's largest vaccine...

    July 12, 2017
  • First vaccine shows gonorrhoea protection

    First vaccine shows gonorrhoea protection

    A meningitis vaccine has been shown to protect against gonorrhoea, making it the first drug to prevent sexually transmitted disease that is increasingly becoming resistant to antibiotics, scientists said on Tuesday. Last week, the World Health Organization (WHO) warned that antibiotic resistance is making gonorrhoea “much harder and sometimes impossible” to treat and new drugs...

    July 11, 2017
  • New experimental Ebola vaccine found safe in humans

    New experimental Ebola vaccine found safe in humans

    Canadian researchers in a clinical trial have developed a vaccine for disease caused by Ebola virus. The study found that the recombinant vesicular stomatitis virus-Zaire Ebola virus (rVSV-ZEBOV) is well-tolerated and showed no safety concerns. The rVSV-ZEBOV is a recombinant, replication competent vesicular stomatitis virus-based candidate vaccine expressing a surface glycoprotein of Zaire Ebola virus....

    June 19, 2017
  • Delay in ‘Made in India’ chikungunya vaccine, researchers seek govt intervention

    Delay in ‘Made in India’ chikungunya vaccine, researchers seek govt intervention

    India offers a rare ray of hope for an indigenously-made vaccine against chikungunya, but delay in finding volunteers is impeding its development. With chikungunya spreading very fast in the country, researchers are seeking urgent government intervention for speedy completion of the vital clinical trials. Chikungunya is a dreaded infection transmitted through the bite of mosquito....

    June 18, 2017
  • New vaccine against rotavirus could curb child deaths

    New vaccine against rotavirus could curb child deaths

    A new vaccine that is cheap to make and does not require refrigeration has shown promise in preventing rotavirus, a contagious and fatal disease that disproportionately strikes children in Africa, researchers have said. A trial in Niger found that the new vaccine was almost 67 per cent effective in preventing gastroenteritis caused by rotavirus, which...

    March 23, 2017
  • HIV vaccine efficacy study begins in South Africa

    HIV vaccine efficacy study begins in South Africa

    The first HIV vaccine efficacy study in seven years has begun in South Africa to test whether a modified vaccine candidate can provide effective protection against the AIDS virus, the US National Institutes of Health said. The study — called HVTN 702 — aims to enroll 5,400 sexually active men and women aged 18 to...

    November 29, 2016